|
| 
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
 |
China plans Asia's largest CMO
 |
|
| China is planning to build Asia's largest biopharmaceutical CMO in Beijing at an investment of $120 mn. Three companiesAutekBio, SUMA Ventures and Beijing E-Town Harvest International Capital Management, have come forward to build the facility |
|
|
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
Protecting and Policing IPRs in China
|
|
| China has become a market of importance. To remain globally competitive, businesses cannot afford to ignore China. So, how can businesses that deal with IP tame the Chinese dragon? |
|
|
|
|
|
All Eyes on Chinese healthcare market
|
|
| The overall compound annual growth rate of the pharmaceutical market (2009-2013), for its part, is projected to be 24%, with the market reaching an estimated $73 billion by 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Lady behind Sundia's success: Dr Xiaochuan Wang, China
|
|
| Sundia, a Shanghai-based integrated pharmaceutical contract research organization is the brainchild of a highly motivated Chinese researcher, Dr Xiaochuan Wang, who worked in the US for over 14 years in three biotech companies after her PhD |
|
|
|
|
|
Simcere names Dr Yehong Zhang as President
|
|
| Dr Zhang has over 18 years of experience in the healthcare industry, most recently serving as a Senior Healthcare Practice Leader in McKinsey's China office focusing on systemic issues impacting the healthcare industry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
|
|
Confronting challenges in China's healthcare industry
|
|
| The 3rd Annual China Healthcare Congress (part of Noppen's Healthcare event series) was held earlier this month in Shanghai, China and brought together the largest panel of experts across Chinas healthcare industry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
3SBio applies for NuPIAO phase I clinical trial with SFDA
|
|
| 3SBio, a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products in China, has submitted its application for a Phase I clinical trial for NuPIAO to the Chinese SFDA |
|
|
|
|
|
China Sky One progresses in SCD detection Kit R&D
|
|
| China Sky One Medical has announced that the Research & Development project for the company's Sudden Cardiac Death (SCD) early examination kit has been appraised by the Heilongjiang Bureau of Science and Technology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
WuXi's Shanghai facilities pass EMEA inspection
|
|
| WuXi PharmaTech has received the formal certificate of GMP compliance from the Medical Products Agency of Sweden, acting on behalf of the European Medicines Agency (EMEA), for its c-GMP drug facilities in Shanghai, China |
|
|
|
|
|
WuXi's toxicology facility gets AAALAC accreditation
|
|
| China-based WuXi PharmaTech's Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
